throbber
Trials@uspto.gov
`571-272-7822
`
`Paper 58
`Entered: October 20, 2016
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________
`
`ARKEMA FRANCE,
`Petitioner,
`
`v.
`
`HONEYWELL INTERNATIONAL, INC.,
`Patent Owner.
`____________
`
`Case IPR2015-00916
`Patent 8,710,282 B2
`____________
`
`
`
`Before JO-ANNE M. KOKOSKI, JON B. TORNQUIST, and
`ROBERT A. POLLOCK, Administrative Patent Judges.
`
`KOKOSKI, Administrative Patent Judge.
`
`DECISION
`Petitioner’s Motion to Exclude Evidence
`37 C.F.R. § 42.64(c)
`
`
`
`
`
`
`

`

`IPR2015-00916
`Patent 8,710,282 B2
`
`
`Arkema France (“Petitioner”) moves to exclude from evidence certain
`exhibits filed by Honeywell International, Inc. (“Patent Owner”) (Paper 46,
`“Mot.”). Patent Owner filed an Opposition (Paper 50, “Opp.”), and
`Petitioner filed a Reply (Paper 51, “Reply”). For the following reasons,
`Petitioner’s motion is granted-in-part and denied-in-part.
`Pursuant to our Rules, a motion to exclude evidence must be filed to
`preserve any previously-made objections to evidence. 37 C.F.R. § 42.64(c).
`The motion must identify where in the record the objections were made, and
`must explain the objections. Id. Petitioner’s Motion seeks to exclude the
`following exhibits on the ground that they are not properly authenticated:
`
`Exhibit
`2007
`2009
`
`2014
`2017
`2020
`2023
`2025
`2027
`2028
`
`
`
`Description from Exhibit List (Paper 21, vi–vii)
`March 26, 2008 email from Haluk Kopkalli
`Project Permit Change Form to Permit # 626 dated May 16,
`2008
`August 2008 Monthly Highlights Report of Dr. Tung
`September 2008 Monthly Highlights Report of Dr. Tung
`November 2008 Monthly Highlights Report of Dr. Tung
`January 2009 Monthly Highlights Report of Dr. Tung
`February 2009 Monthly Highlights Report of Dr. Tung
`March 2009 Monthly Highlights Report of Dr. Tung
`PowerPoint entitled “Apollo Technology Review
`Dehydrofluorination of 236ea and 245eb” and dated August
`21, 2009
`
`Petitioner identifies where in the record it previously served
`objections to these exhibits (Mot. 2 (citing Paper 23)), and the Motion is,
`therefore, procedurally proper. As the moving party, Petitioner bears the
`burden of proof to establish that it is entitled to the requested relief: the
`exclusion of the evidence as inadmissible under the Federal Rules of
`Evidence (“FRE”). See 37 C.F.R. §§ 42.20(c), 42,64(a).
`
`
`
`2
`
`

`

`IPR2015-00916
`Patent 8,710,282 B2
`
`
`Federal Rule of Evidence 901(a) states that, “[t]o satisfy the
`requirement of authenticating or identifying an item of evidence, the
`proponent must produce evidence sufficient to support a finding that the
`item is what the proponent claims it is.” The Rule provides several
`examples of evidence that may satisfy the requirement, including the
`testimony of a witness with knowledge that the item is what it is claimed to
`be. FRE 901(b)(1). Patent Owner argues that it “relies on testimony from
`multiple witnesses combined with the appearance, contents, and substance of
`each exhibit” in order authenticate the exhibits. Opp. 1 (emphasis omitted).
`Exhibit 2007
`A.
`Patent Owner provides the testimony of named inventor Dr. Harry S.
`Tung that Exhibit 2007 is “a true and accurate copy of the Kopkalli Email
`dated March 26, 2008 and associated attachments which [Dr. Tung] received
`from Mr. Kopkalli in the ordinary course of business.” Ex. 2006 ¶ 11.
`Patent Owner argues that this testimony, along with the contents of Exhibit
`2007, establishes that “there is at least a reasonable likelihood that Exhibit
`2007 contains the Kopkalli e-mail.” Opp. 8–9.1 Petitioner argues that,
`because Patent Owner relies on Exhibit 2007 to corroborate Patent Owner’s
`argument and Dr. Tung’s testimony that the claimed invention was
`conceived by March 26, 2008, “Dr. Tung’s declaration is insufficient to
`properly authenticate Exhibit 2007.” Mot. 3–5.
`Normally, the testimony of Dr. Tung—a witness having personal
`knowledge of the documents—could be sufficient to “support a finding that
`
`1 Patent Owner also cites to additional testimony from Dr. Tung in the
`“Tung Supplement Declaration.” Opp. 9. Because the Tung Supplemental
`Declaration does not appear to be in the record, this testimony is
`unsupported and we do not consider it in our analysis.
`3
`
`
`
`

`

`IPR2015-00916
`Patent 8,710,282 B2
`
`the item is what the proponent claims it is,” the context in which this exhibit
`is offered requires more. Specifically, because Patent Owner relies on
`Exhibit 2007 to corroborate Dr. Tung’s testimony that Exhibit 2007
`demonstrates conception of the claimed invention at least as early as March
`26, 2008, independent evidence of authenticity is required:
`It is well established that in order for a contemporaneous
`document to be accorded any corroborative value[,] the
`testimony of a witness other than the inventor, who is shown to
`have understood the recorded information, is generally necessary
`to authenticate the document’s contents as well as to explain the
`witness’ relationship to the document in question.
`Horton v. Stevens, 7 U.S.P.Q. 2d 1245, 1988 WL 252359 at *4 (BPAI Mar.
`8, 1988) (emphasis added). This is to avoid “circular” situations in which a
`party seeks to rely on a document to corroborate a witness’ testimony, but
`relies on that witness’ testimony to provide the date or other authentication
`of that document. See In re NTP, Inc., 654 F.3d 1279, 1297 (Fed. Cir.
`2011); Chen v. Bouchard, 347 F.3d 1299, 1308 (Fed. Cir. 2003) (rejecting
`authentication of a document because it was not established by anything
`other than the circular testimony of the inventor). The purpose of
`corroboration is to prevent fraud by providing independent confirmation of
`the inventor’s testimony. See, e.g., Kridl v. McCormick, 105 F.3d 1446,
`1450 (Fed. Cir. 1997) (“The tribunal must also bear in mind the purpose of
`corroboration, which is to prevent fraud, by providing independent
`confirmation of the inventor’s testimony.”). A document authenticated only
`by an inventor does not achieve that purpose because it is not sufficiently
`independent.
` For this reason, Dr. Tung’s testimony cannot be used to authenticate
`Exhibit 2007, when Exhibit 2007 is offered to corroborate Dr. Tung’s
`
`
`
`4
`
`

`

`IPR2015-00916
`Patent 8,710,282 B2
`
`testimony regarding the conception date of the claimed invention. We
`determine that Exhibit 2007 should be excluded as lacking authentication
`under FRE 901.
`Exhibit 2009
`B.
`Patent Owner provides the testimony of Angela Goodie and Diana
`Overton in order to authenticate Exhibit 2009. Opp. 13–15 (citing Exs.
`2037, 2040). Ms. Goodie testifies that she performed experiments in July
`2008 according to instructions received from Dr. Selma Bektesevic, “using
`the lab setup described in the Project Permit Change Form (EX2009).”
`Ex. 2037 ¶ 4. Ms. Overton testifies to Patent Owner’s policies with respect
`to the preparation and retention of project permit change forms such as
`Ex. 2009, including that it is the policy
`for researchers or scientists to prepare permits or permit change
`forms in order to pursue experiments and changes or addendums
`thereto (such as process, chemicals, people), respectively. Once
`the permit or permit change form is approved by the appropriate
`personnel, the signed original of the document is routed to the
`[Health, Safety and Environment] department, where it is
`maintained in the ordinary course of business.
`Ex. 2040 ¶ 5.
`Petitioner argues that “Ms. Goodie never states that Exhibit 2009 is a
`true and accurate copy of the original Project Permit Change Form dated
`May 16, 2008,” and Ms. Overton did not work at Patent Owner in her
`current capacity until June 2015, and thus does not have personal knowledge
`related to Exhibit 2009. Mot. 6–8. Patent Owner responds that
`“Ms. Goodie’s testimony and the ‘appearance, contents, [or] substance’ of
`Exhibit 2009 demonstrate at least a ‘reasonable likelihood’ that Exhibit 2009
`contains the Project Permit Change Form received by Angela Goodie on or
`
`
`
`5
`
`

`

`IPR2015-00916
`Patent 8,710,282 B2
`
`near July 16, 2008.” Opp. 13. Patent Owner also argues that “Ms. Overton
`testified only to her personal knowledge as a record-keeper of the process
`for keeping records in the past.” Id. at 14–15.
`We determine that Ms. Goodie’s testimony that she used the lab setup
`described in Exhibit 2009 to perform experiments following
`Dr. Bektesevic’s instructions, coupled with identifying information on
`Exhibit 2009 (such as the identification of Dr. Bektesevic as the “sender” of
`the form and the employee responsible for the project), is adequate to
`support a finding that Exhibit 2009 is the Project Permit Change Form to
`Permit # 626 dated May 16, 2008 as Patent Owner claims. Ms. Overton’s
`testimony regarding Patent Owner’s document retention practices further
`supports this determination. Accordingly, we decline to exclude Exhibit
`2009.
`
`Exhibits 2014, 2017, 2020, 2023, 2025, and 2027
`C.
`Patent Owner provides testimony from Dr. Tung in order to
`authenticate Exhibits 2014, 2017, 2020, 2023, 2025, and 2027 (collectively,
`“the Tung Monthly Highlights”). Ex. 2006 ¶¶ 33, 39, 44, 47, 49, 51. Patent
`Owner argues that Dr. Tung testified from his personal knowledge that the
`Tung Monthly Highlights are true and accurate copies, and that Dr. Tung’s
`testimony, along with the date, title, and identified author of each exhibit,
`establishes that “there is at least a reasonable likelihood” that the Tung
`Monthly Highlights are authentic. Opp. 9–12. Petitioner argues that Patent
`Owner relies on the Tung Monthly Highlights “to support and corroborate
`arguments and testimony related to diligence,” and, as discussed above with
`respect to Exhibit 2007, Dr. Tung’s testimony cannot authenticate
`
`
`
`6
`
`

`

`IPR2015-00916
`Patent 8,710,282 B2
`
`corroborating documents because it is not sufficiently independent. Mot. 8–
`9.
`
`For the reasons set forth above with respect to Exhibit 2007,
`Dr. Tung’s testimony cannot be used to authenticate the Tung Monthly
`Highlights, when the Tung Monthly Highlights are offered to corroborate
`Dr. Tung’s testimony regarding diligence. We determine that Exhibits 2014,
`2017, 2020, 2023, 2025, and 2027 should be excluded as lacking
`authentication under FRE 901.
`Exhibit 2028
`D.
`Patent Owner provides testimony from Dr. Tung in order to
`authenticate Exhibit 2028. Ex. 2006 ¶ 53. Patent Owner argues that
`Dr. Tung testified “from his personal knowledge that Exhibit 2028 is a true
`and authentic copy of a presentation related to the caustic
`dehydrofluorination experiments given by Dr. Bektesevic at a meeting on
`May 13, 2009,” and that Dr. Tung’s testimony also “confirms the contents of
`the slides.” Opp. 12. Petitioner argues that Exhibit 2028 “does not have an
`indication of source or authorship” (Reply 5), and that, because Dr. Tung
`relies on Exhibit 2028 to support and corroborate arguments related to
`diligence, Dr. Tung’s testimony cannot authenticate Exhibit 2028 because it
`is not sufficiently independent (Mot. 10; Reply 5).
`For the reasons set forth above with respect to Exhibit 2007,
`Dr. Tung’s testimony cannot be used to authenticate Exhibit 2028, when
`Exhibit 2028 is offered to corroborate Dr. Tung’s testimony regarding
`diligence. We determine that Exhibit 2028 should be excluded as lacking
`authentication under FRE 901.
`
`
`
`
`7
`
`

`

`IPR2015-00916
`Patent 8,710,282 B2
`
`
`ORDER
`In consideration of the foregoing, it is
`ORDERED that Petitioner’s Motion to Exclude Evidence is granted-
`
`in-part with respect to Exhibits 2007, 2014, 2017, 2020, 2023, 2025, 2027,
`and 2028, and otherwise is denied-in-part.
`
`
`PETITIONER:
`
`Jon Beaupré
`Allen R. Baum
`Allyn B. Elliott
`Joshua E. Ney
`Richard K. DeMille
`BRINKS GILSON & LIONE
`jbeaupre@brinksgilson.com
`Arkema_HoneywellIPRs@brinksgilson.com
`
`
`
`PATENT OWNER:
`
`Bruce J. Rose
`Christopher TL Douglas
`S. Benjamin Pleune
`ALSTON & BIRD LLP
`bruce.rose@alston.com
`chris.douglas@alston.com
`ben.pleune@alston.com
`
`
`
`
`
`
`
`8
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket